For the first time ever, Medicare will cover drugs like Wegovy and Zepbound. But a strict BMI checklist and a 2027 deadline ...

Some Medicare beneficiaries are getting access to weight loss drugs this month through a so-called Bridge program. But ...

Millions could meet criteria to receive GLP-1s, which could cost Medicare billions of dollars, according to a report by KFF.

WASHINGTON - Eligible Medicare beneficiaries can now obtain certain anti-obesity medications for $50 a month under a new ...

A Medicare pilot program could expand access to GLP-1 weight-loss drugs for millions of seniors while lowering monthly costs ...

For the first time, Medicare will cover GLP-1 drugs prescribed solely for weight loss for eligible beneficiaries at a $50 ...

Does Medicare pay for GLP-1 drugs like Ozempic for weight loss? For years, the answer has been a hard no. But a new “Bridge” ...

Some Medicare beneficiaries could soon pay a flat $50 for GLP-1 drugs. Learn who qualifies, what employers may do, and what ...

GLP-1 weight loss drugs will be a lot cheaper for many older Americans with the rollout of Medicare’s $50-a-month GLP-1 ...

GoodRx reports that Medicare's new GLP-1 Bridge program allows eligible Part D enrollees to access weight-loss medications ...

Medicare is launching a temporary program that will cover Novo’s Wegovy injection and tablets, as well as Lilly’s Zepbound ...

The Trump administration has officially launched its new "bridge" model that brings GLP-1 coverage for weight loss to Medicare beneficiaries. | The Trump administration has officially launched its new ...